Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 10 | 2020 | 509 | 1.680 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2025 | 34 | 0.950 |
Why?
|
| Preoperative Care | 4 | 2017 | 354 | 0.770 |
Why?
|
| Hemoglobin, Sickle | 4 | 2010 | 21 | 0.760 |
Why?
|
| Postoperative Complications | 6 | 2025 | 3062 | 0.730 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 39 | 0.710 |
Why?
|
| Aspirin | 3 | 2017 | 224 | 0.700 |
Why?
|
| Proteins | 4 | 2010 | 1036 | 0.660 |
Why?
|
| Leukemia | 2 | 2022 | 369 | 0.640 |
Why?
|
| Solutions | 6 | 2010 | 65 | 0.560 |
Why?
|
| Syndrome | 2 | 2022 | 1119 | 0.540 |
Why?
|
| Coronary Vessels | 2 | 2020 | 537 | 0.540 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2025 | 670 | 0.540 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2016 | 106 | 0.520 |
Why?
|
| Coronary Artery Disease | 3 | 2020 | 769 | 0.510 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2013 | 349 | 0.470 |
Why?
|
| Exercise | 2 | 2022 | 787 | 0.440 |
Why?
|
| Cognition | 1 | 2018 | 707 | 0.440 |
Why?
|
| Models, Genetic | 1 | 2016 | 759 | 0.430 |
Why?
|
| Protein Conformation | 4 | 2010 | 830 | 0.420 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 778 | 0.420 |
Why?
|
| Heme | 2 | 2010 | 52 | 0.410 |
Why?
|
| Renal Insufficiency | 3 | 2010 | 235 | 0.400 |
Why?
|
| Heart Atria | 2 | 2012 | 315 | 0.400 |
Why?
|
| Sodium | 1 | 2013 | 295 | 0.400 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 42 | 0.380 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 206 | 0.370 |
Why?
|
| Genetic Variation | 1 | 2016 | 1493 | 0.340 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 1112 | 0.330 |
Why?
|
| Models, Chemical | 3 | 2009 | 86 | 0.330 |
Why?
|
| Crystallization | 4 | 2023 | 83 | 0.330 |
Why?
|
| Viscoelastic Substances | 1 | 2009 | 2 | 0.320 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 173 | 0.300 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 138 | 0.300 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 204 | 0.300 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 125 | 0.290 |
Why?
|
| Obesity | 3 | 2009 | 2258 | 0.290 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 161 | 0.290 |
Why?
|
| Heart Ventricles | 1 | 2012 | 764 | 0.280 |
Why?
|
| Scattering, Radiation | 5 | 2010 | 50 | 0.270 |
Why?
|
| Biophysics | 1 | 2006 | 50 | 0.270 |
Why?
|
| Stroke | 1 | 2013 | 974 | 0.250 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 262 | 0.250 |
Why?
|
| Thermodynamics | 4 | 2010 | 142 | 0.240 |
Why?
|
| Kinetics | 6 | 2010 | 1321 | 0.240 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 436 | 0.240 |
Why?
|
| Diabetes Complications | 1 | 2006 | 198 | 0.230 |
Why?
|
| Aged | 11 | 2025 | 19533 | 0.230 |
Why?
|
| Retrospective Studies | 12 | 2025 | 16275 | 0.230 |
Why?
|
| Humans | 27 | 2025 | 124175 | 0.210 |
Why?
|
| Antimalarials | 1 | 2023 | 39 | 0.210 |
Why?
|
| Malaria | 1 | 2023 | 85 | 0.200 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12288 | 0.200 |
Why?
|
| Models, Molecular | 2 | 2007 | 1069 | 0.200 |
Why?
|
| Quinolines | 1 | 2023 | 98 | 0.200 |
Why?
|
| Male | 15 | 2025 | 60998 | 0.200 |
Why?
|
| Nerve Block | 1 | 2022 | 64 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2015 | 240 | 0.190 |
Why?
|
| Fatigue | 2 | 2022 | 186 | 0.190 |
Why?
|
| Heart-Assist Devices | 1 | 2009 | 1035 | 0.180 |
Why?
|
| Propensity Score | 2 | 2020 | 215 | 0.180 |
Why?
|
| Risk Factors | 7 | 2025 | 10245 | 0.170 |
Why?
|
| Middle Aged | 10 | 2025 | 26588 | 0.170 |
Why?
|
| Light | 4 | 2009 | 176 | 0.170 |
Why?
|
| Cardioplegic Solutions | 1 | 2020 | 17 | 0.170 |
Why?
|
| Databases, Factual | 1 | 2025 | 1173 | 0.170 |
Why?
|
| Heart Arrest, Induced | 1 | 2020 | 75 | 0.170 |
Why?
|
| Female | 14 | 2025 | 66275 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2016 | 646 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1688 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 167 | 0.150 |
Why?
|
| Nausea | 1 | 2018 | 83 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 2 | 2022 | 192 | 0.150 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 722 | 0.150 |
Why?
|
| Phase Transition | 2 | 2010 | 17 | 0.150 |
Why?
|
| Time Factors | 6 | 2017 | 6283 | 0.150 |
Why?
|
| Algorithms | 3 | 2016 | 1606 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 730 | 0.140 |
Why?
|
| Heart Failure | 1 | 2010 | 2287 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 166 | 0.130 |
Why?
|
| Cohort Studies | 4 | 2020 | 4780 | 0.130 |
Why?
|
| Pain | 1 | 2018 | 447 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2018 | 450 | 0.120 |
Why?
|
| Atrial Appendage | 1 | 2015 | 46 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1318 | 0.120 |
Why?
|
| Cause of Death | 1 | 2017 | 473 | 0.120 |
Why?
|
| Survival Rate | 2 | 2017 | 2037 | 0.110 |
Why?
|
| Intraoperative Period | 1 | 2013 | 74 | 0.110 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 41 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 99 | 0.100 |
Why?
|
| Texas | 3 | 2017 | 3577 | 0.100 |
Why?
|
| Quality of Life | 1 | 2022 | 1899 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 120 | 0.100 |
Why?
|
| Perfusion | 1 | 2013 | 201 | 0.100 |
Why?
|
| Exome | 1 | 2016 | 1035 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2013 | 166 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 869 | 0.090 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 631 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 222 | 0.090 |
Why?
|
| Reoperation | 2 | 2013 | 830 | 0.090 |
Why?
|
| Depression | 1 | 2018 | 1213 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5132 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 128 | 0.080 |
Why?
|
| Temperature | 2 | 2010 | 303 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2022 | 13997 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1682 | 0.080 |
Why?
|
| Protein Folding | 1 | 2010 | 216 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2009 | 113 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 48 | 0.080 |
Why?
|
| Prognosis | 2 | 2020 | 4609 | 0.080 |
Why?
|
| Viscosity | 1 | 2009 | 36 | 0.080 |
Why?
|
| Muramidase | 1 | 2009 | 94 | 0.080 |
Why?
|
| Cardiac Output, Low | 1 | 2009 | 67 | 0.080 |
Why?
|
| Thrombectomy | 1 | 2009 | 106 | 0.080 |
Why?
|
| Hematoma | 1 | 2009 | 93 | 0.080 |
Why?
|
| Elasticity | 1 | 2009 | 90 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2013 | 3430 | 0.080 |
Why?
|
| Cytosol | 1 | 2009 | 161 | 0.080 |
Why?
|
| Multienzyme Complexes | 2 | 2007 | 88 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 528 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 659 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2629 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 575 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2012 | 932 | 0.070 |
Why?
|
| Adolescent | 3 | 2022 | 19243 | 0.070 |
Why?
|
| Logistic Models | 4 | 2015 | 1799 | 0.070 |
Why?
|
| Phenotype | 1 | 2016 | 4251 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2006 | 100 | 0.070 |
Why?
|
| Length of Stay | 2 | 2009 | 1303 | 0.070 |
Why?
|
| Polymers | 1 | 2006 | 106 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2020 | 329 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2006 | 303 | 0.060 |
Why?
|
| Morbidity | 1 | 2006 | 246 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 144 | 0.060 |
Why?
|
| Child | 3 | 2022 | 24356 | 0.060 |
Why?
|
| Thrombosis | 1 | 2009 | 518 | 0.060 |
Why?
|
| Inpatients | 1 | 2009 | 492 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 436 | 0.060 |
Why?
|
| Hemin | 1 | 2023 | 17 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2012 | 1252 | 0.050 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 338 | 0.050 |
Why?
|
| Hospital Mortality | 3 | 2013 | 1022 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 1010 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1421 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 585 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 261 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 413 | 0.040 |
Why?
|
| Erythrocytes | 2 | 2010 | 212 | 0.040 |
Why?
|
| Adult | 3 | 2022 | 29339 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 1421 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 135 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 87 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 779 | 0.030 |
Why?
|
| Mutation | 1 | 2006 | 5817 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2010 | 847 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 668 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 2882 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2013 | 308 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 98 | 0.020 |
Why?
|
| Heart Valves | 1 | 2010 | 50 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 431 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6120 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2141 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2010 | 195 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 2007 | 31 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2007 | 85 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 184 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 49 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 95 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2005 | 57 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6464 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3134 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 2007 | 336 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2009 | 1555 | 0.010 |
Why?
|